Abstract
Introduction
Parkinson's disease (PD), a progressive neurodegenerative disorder characterized by resting tremor, muscular rigidity and gait disturbances [1, 2] , is pathologically characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and their termini in their dorsal stratium [3] . The pathological hallmark of PD is the presence of deposits of aggregated ␣-synuclein (␣Syn) in intracellular inclusions known as Lewy bodies (LB) [4, 5] . Three missense mutations, A53T, A30P and proteins. ␣Syn is a 140-amino acid protein that is highly expressed in pre-synaptic terminals, in particular in the neocortex, hippocampus and SN [10] , but is also found in other regions of neurons as well as within astrocytes and oligodendroglia [11, 12] . It is known to interact with a variety of proteins [13, 14] and also with lipid vesicles [15] , and it may be involved in lipid metabolism [16, 17] . In its free state ␣Syn is intrinsically disordered, with no well-defined structure as determined in vitro, although NMR studies have shown long-range interactions between the acidic C-terminal region and the amyloidogenic central region [18] [19] [20] . Interactions with acidic phospholipids membranes result in induction of helical conformation in its N-terminal region [21, 22] .
The physiological functions of ␣Syn are still being established. Its interaction with pre-synaptic membranes suggests that one function may be the regulation of synaptic vesicle pools, including dopamine control [23] . A role as a molecular chaperone, assisting in the folding and refolding of certain synaptic proteins, was also proposed [24] . Although ␣Syn is normally considered as a cytoplasmic protein, it has also been found to be present in extracellular biological fluids, including human cerebrospinal fluid and blood plasma [25, 26] . One mechanism that leads to the presence of extracellular ␣Syn is thought to be membrane permeability as a result of cell death, although it has also been reported that monomeric and aggregated ␣Syn may be secreted by an unconventional endoplasmic reticulum/Golgi-independent exocytosis pathway [26] .
␣Syn can self-assemble in vitro to form ordered fibrillar aggregates, characterized by a cross ␤-sheet structure, that are morphologically similar to the aggregates found in LB, in neuritic plaques in Alzheimer's disease (AD) as well as in deposits associated with other amyloidogenic processes (reviewed in [27] ). A significant international effort has been made to elucidate the biophysical basis for the aggregation of ␣Syn [28, 29] . The initial phase of the aggregation process is thought to involve the formation of oligomeric species which, according to accumulating experimental evidence, are more toxic to cells than the mature fibrils into which they develop [30, 31] . These and other findings suggest a common structure-linked toxicity among prefibrillar species, and it has been proposed that similar mechanisms may in general contribute to pathogenesis for this group of diseases [32, 33] . Overall, many hypotheses have been put forward that propose that ␣Syn induces a 'gain of toxic function' upon aggregation [27] .
Importance of inflammation processes in PD pathology
Inflammation is the first response of the immune system to pathogens. In acute conditions, it protects tissue against invading agents and promotes healing. However, when sustained chronically, it can cause serious damage to the host's own tissue [34] . [34] ). A robust and highly localized inflammatory response mediated by reactive microglia and reactive astrocytes is prominent in affected areas of the SN in PD brains (reviewed in [34] ).
Although the central nervous system (CNS) has been traditionally seen as an immune-privileged organ, it has become increasingly evident that inflammation is actively involved in the pathogenesis of many degenerative diseases including multiple sclerosis (MS), AD, and PD (see references in
Microglia are the main immunocompetent cells within the CNS [35] , capable of antigen presentation to lymphocytes [36] and rapid activation in response to pathological change in the CNS [34] . Microglial [37, 38] . In addition, they start releasing inflammatory cytokines that amplify the inflammatory response by activating and recruiting other cells to the brain lesion [34] . Microglia can also release potent neurotoxins, which may cause neuronal damage, and, indeed, sustained overactivation of microglia has been observed in a variety of neurodegenerative diseases [34] .
Evidence of microglial attack in PD is supported by findings within three different areas of research: epidemiological studies, animal models and cells in culture [39] . Epidemiological studies that investigated the effects of using anti-inflammatory agents showed that taking ibuprofen regularly was associated with a 35% lower risk of PD [40, 41] [39] . In addition, the transgenic mouse models for PD that have been described utilize neuron-specific promoters to overexpress Wt or mutant ␣Syn locally (reviewed in [44, 45] [45, 46] and that microglial cells can be activated to mount such an attack [47] .
Stimulation of microglia by ␣Syn
Several studies have demonstrated that extracellular and nigral aggregates immunoreactive to ␣Syn are often surrounded by activated microglia or inflammatory mediators [48, 49] [54] [55] [56] . Therefore, although PD is not an autoimmune disease, evidence of localized attack by microglia places it in the autotoxic category [39] .
Several recent in vitro studies have focused on the effects of extracellular ␣Syn on microglial activation (Table 1) . Zhang et al. [54] first reported that exogeneous, aggregated ␣Syn activates microglial cells, which then become toxic towards cultured dopaminergic neurons. This is particularly relevant, because aggregated ␣Syn has been shown to be secreted by exocytosis from neuronal cells [26] although it might also be released by membrane permeability from dead cells [57] . The study found that microglial phagocytosis of ␣Syn and activation of NADPH oxidase were critical in microglial activation induced by aggregated ␣Syn, and neurotoxicity [54] . The toxicity level was lower in mice null for NADPH oxidase, indicating that oxygen-free radicals generated by the activated microglia, are likely to play a significant role in neurotoxicity. It was also reported that induction of NADPH oxidase is linked to direct activation of the Mac-1 receptor, and not by ␣Syn internalization via a scavenger [58] . Finally, it was proposed that nigral neuronal damage, regardless of its aetiology, might release aggregated ␣Syn, which could then lead to persistent and progressive neuronal damage [58] .
Several works have concluded that the mutated, disease-causing forms of ␣Syn are more potent stimuli of microglial activation than the Wt protein, indicating a possible molecular mechanism for the increased toxicity of the ␣Syn mutants linked to familial PD [57] . Likewise, it has been shown that aggregated ␣Syn has a stronger stimulating effect on microglia [56] than that of nonaggregated ␣Syn (Table 1 ). Recent investigations demonstrated that aggregated ␣Syn induces a neurotoxic inflammatory microglial phenotype that accelerates dopaminergic neuron loss [54, 56, 59, 60] . By integrating genomic and proteomic techniques, Gendelman and coworkers [61] [63] ).
␣Syn-triggered stimulation of the innate immune system
Upon activation, microglia and astrocytes can secrete neurotoxic products and inflammatory cytokines [39] . The latter ones are produced in order to communicate and orchestrate the immune response to disease, or injury, often by inducing proliferation [64] . [54] . Oxidation [62, 69] and nitration [51, 62] [70] .
The cytokines TNF-␣, IL-1␤, IL-2, IL-4, IL-6, tumour growth factor (TGF)-␣, TGF-␤1, TGF-␤2 have all been reported to be present at higher levels in the nigrostriatal region and cerebrospinal fluid of patients with PD or dementia with LB ([64] and references therein
Recently, McGeer and coworkers [71] [71] .
Other proteins up-regulated by ␣Syn-triggered microglial activation

Reynolds et al. [61], by determining the activated microglia proteome profile, found that aggregated N-␣Syn activation of microglia results in differential expression of several proteins (Table 1). These range from proteins involved in oxidative stress, cell adhesion, glycolysis, regulation of growth, and migration, to proteins of the cytoskeleton. It is intriguing that two of those proteins found to be particularly highly up-regulated, calmodulin and ubiquitin, have been shown to interact with ␣Syn with possible functional consequences. Calmodulin has been shown, in vitro, to bind to ␣Syn in a Ca
2ϩ
-dependent manner [73] and to inhibit fibrillation of ␣Syn [74] . Several studies have reported that a fraction of ␣Syn found in LB is mono-ubiquitinated [75, 76] [77, 78] and stimulating apoptosis [78] . There is also evidence implicating a role for the ubiquitin-proteasome system (UPS) in PD (reviewed in [79] [80] [81] [82] [83] . Also of interest in activated microglia expression profile are the elevated levels of Hsp70. This chaperone has been demonstrated to inhibit ␣Syn aggregation in vitro [84] , in neuroglioma cells [85] , as well as in fly [86] and mouse [85] [87] . In addition to cytokines, apoptosis-related proteins are elevated in the stratium of PD patients [88, 89] .
, but the role of this modification remains unclear. Recently, it has been demonstrated that the ubiquitin-protein isopeptide ligase, seven in absentia homologue, directly interacts with and monoubiquitinates ␣Syn, promoting its aggregation
While searching for a link between the CNS and the peripheral immune system in PD, Kim et al. [90] [49] . As in astrocytes [94] , ␣Syn-containing inclusions have been reported in oligodendrocytes [94, 95] , both in dementia with LB and in PD.
␣Syn and the humoural immune system in PD
The observation in PD patients that small numbers of CD8 ϩ T lymphocytes occur in proximity to degenerating nigral neurons [48] and that components of the classical or antibody-triggered complement cascade occur in LB [49] , suggests that the pathological process may involve humoural-mediated mechanisms [43] . In addition, humoural immune mechanisms can trigger microglial-mediated neuronal injury in animal models of PD [96] .
To analyse the possibility that humoural immunity may play a role in initiating or regulating inflammation, Orr et al. [43] 
Expression of ␣Syn in immunocompetent cells
It has been reported that ␣Syn is also expressed in astrocytes and that its level is increased by stimulation with the pro-inflammatory cytokine IL-1␤ [101] . Also, ␣Syn has been found to be expressed in cultured human macrophages [102] . In this case, ␣Syn protein (but not mRNA) levels were seen to be up-regulated by stimulation with LPS and IL-1␤ [102] [108] .
An interesting strategy is the generation of specific anti-␣Syn single-chain Fv (scFv) antibody fragments that bind either to the monomeric [109] or oligomeric [110] protein, and inhibit its aggregation. These scFvs can be generated such that they only target the toxic oligomeric form of ␣Syn, allowing the monomer to perform its normal function freely [110] , and they can also potentially be expressed intracellularly (intrabodies) to counteract aggregation and reduce neurodegeneration, as recently shown with a neural progenitor cell line [111] , and in an animal model of Huntington's disease [112] .
Given that microglial activation can maintain or even aggravate the disease process, blocking inflammation or shifting the balance between pro-inflammatory and anti-inflammatory states in a controlled manner, offers one of the most promising strategies for developing palliative (and maybe preventative) therapies for PD and related disorders. Epidemiological data has identified the nonsteroidal anti-inflammatory drug ibuprofen as neuroprotective for PD [113] . A variety of other, both endogenous and synthetic compounds that might suppress neuroinflammation in PD by interacting with microglia, have been identified and proposed for therapeutic use (reviewed in [113] 
